🔗 Share this article

Grammy-winning soul vocalist D’Angelo passed away on October 14 at 51 years old after a private battle with pancreatic cancer.

“The shining star of our family has faded away for us in this life,” his family confirmed. “After a lengthy and courageous battle with cancer, we are heartbroken to announce that D’Angelo, known to his fans around the globe as D’Angelo, has been called home.”

D’Angelo left an indelible mark on the music industry with his pioneering neo-soul sound and partnerships with high-profile artists.

He launched his debut album, “Brown Sugar,” in 1995 to immediate acclaim. The album achieved the fourth spot on the R&B charts, earned platinum status later that year, and received multiple award nominations.

However, it was his second album, “Voodoo,” in the year 2000 that boosted his artistic journey into the limelight. The album debuted at No. 1 on each of Billboard’s Top R&B Albums chart and the main album chart. He received two Grammy Awards: Best R&B Album and Outstanding Male Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” cemented D’Angelo’s standing as a icon, albeit a hesitant one, in the public consciousness. The personal depiction showed the artist, famously stripped down to his midsection, singing directly into the lens.

D’Angelo retreated from the spotlight after releasing Voodoo and openly battled with substance abuse. In 2005, he was involved in a severe car crash that put him in critical condition.

More than a decade later, his last record, “Black Messiah” (2014), confirmed his enduring appeal with another No. 1 debut on the soul music rankings and a award for Best R&B Album.

Again, in his own enigmatic fashion, D’Angelo had limited public outings in the following years.

The musician was announced as a headliner for the 2025 music event, but his performance was called off, citing an “unforeseen medical delay.”

Although information is limited about D’Angelo’s well-being in the months before his passing, he had apparently been hospitalized for months and in palliative care for a fortnight.

D’Angelo’s passing is a stark reminder of the harmful impact of pancreatic cancer, one of the deadliest and least preventable forms of the disease, on a gifted artist whose life was cut short.

“We are grieved that he can only provide cherished moments with his family, but we are eternally grateful for the heritage of deeply emotional songs he leaves behind,” his kin expressed.

Pancreatic Malignancy: Lethal and Rarely Preventable

Pancreatic malignancy impacts the pancreas, a small organ that produces the hormone insulin and plays an essential role in breaking down food, among other functions. The position and dimensions of the organ in the body make it more difficult to detect malignancy.

Even though pancreatic cancer accounts for only approximately three percent of malignancy cases each year in the U.S., it is causes 7% of malignancy fatalities.

Nearly 70,000 individuals will be found to have pancreatic cancer and roughly fifty-two thousand will die of the illness in 2025.

“Pancreatic cancer is one of the most lethal diseases, with an aggressive tumor and dismal outcomes. We have limited and poor treatment options, and a narrow opportunity to make a significant difference on the well-being of people,” said a cancer specialist.

Since this disease rarely causes initial signs, it’s often diagnosed only after the condition is advanced. Although a individual has indicators they are usually vague and may be confused with a number of everyday ailments.

“As of yet, there is no good way to detect pancreatic cancer in the early stages, except for listening to your body and consulting your doctor if there are unfamiliar symptoms,” said a medical director.

Frequent indicators of this disease include:

• discomfort in the stomach or back
• weight loss
• yellowing of skin and eyes
• loss of appetite
• brownish urine
• light-colored or greasy stools
• loose stools
• increased appetite or thirst
• nausea

At 51 years old, D’Angelo’s death is an exception, as pancreatic cancer is most common in adults in the 65 to 75 age bracket. However, numerous malignancies, such as this type, have become increasingly prevalent in younger adults.

“This disease diagnosed before the age of 50 is deemed uncommon, yet alarmingly, clinicians are noticing a growing number of younger patients suffering from this disease,” said a specialist.

Genetic Background Affects Disease Probability

Without effective screening tools for pancreatic cancer, experts emphasized the importance of understanding your relatives’ health background. Certain contributing elements, such as smoking and obesity also play a role in the development of this disease.

Black individuals have the highest incidence of pancreatic cancer in the U.S. and are more prone to be diagnosed with untreatable disease.

“The first step toward lowering one’s risk of this condition is understanding personal risk factors. Individuals should review their genetic background, hereditary factors, and health issues, such as diabetes, chronic pancreatitis, or obesity that may raise their vulnerability,” advised a specialist.

Hereditary elements are linked to as much as ten percent of all pancreatic cancer cases. If a relative in your household has had this disease, you may want to consider DNA analysis.

“For individuals with a family history of pancreatic cancer or those carrying elevated risk DNA changes, checking may involve advanced imaging such as MRI scans or internal ultrasound to detect initial alterations in the pancreas,” he explained.

For those looking to lower their chance, habit adjustments may have an effect. The most effective action you can take to lower your risk of this disease is to stop tobacco use, and if you are a non-smoker, avoid exposure altogether.

Heavy alcohol consumption is linked to pancreas inflammation, a contributing element for pancreatic cancer, so reducing or abstaining from alcohol may assist reduce your risk.

Managing your body mass or losing weight may also help decrease your susceptibility. Individuals with obesity are 20% more likely to get this disease. Pancreatic cancer also occurs more often in those with diabetes, and reducing weight can also reduce the risk of type 2 diabetes.

Despite this disease’s poor prognosis, there is reason for optimism.

“We are doing better with treatments and more recent mixed drug treatments. There are developing precision medicines that are already showing results,” remarked a specialist.

For many individuals, however, awareness about this rare but {dev